Tumor Time‐Course Predicts Overall Survival in Non‐Small Cell Lung Cancer Patients Treated With Atezolizumab: Dependency on Follow‐Up Time

CPT: Pharmacometrics and Systems Pharmacology - United States
doi 10.1002/psp4.12489
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Sphingosine Kinase‑1 Predicts Overall Survival Outcomes in Non‑small Cell Lung Cancer Patients Treated With Carboplatin and Navelbine

Oncology Letters
Cancer ResearchOncology
2019English

Modeling Tumor Dynamics and Overall Survival in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Effects of Biological Markers on Overall Survival in Surgically Treated Patients With Non Small Cell Lung Cancer

Vojnosanitetski Pregled
MedicinePharmacology
2020English

Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Peripheral Immune Cell Gene Expression Predicts Survival of Patients With Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2012English

Effect of Tumor Size on Survival in Pn0m0 Non-Small Cell Lung Cancer Patients

Current Thoracic Surgery
2016English

A Pharmacodynamic Model for the Time Course of Tumor Shrinkage by Gemcitabine + Carboplatin in Non-Small Cell Lung Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2008English

Fever and Survival With Drug-Treated Non-Small Cell Lung Cancer.

Kurume Medical Journal
Medicine
2001English

The M1 Form of Tumor-Associated Macrophages in Non-Small Cell Lung Cancer Is Positively Associated With Survival Time

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy